Latest / A Canadian Celiac Podcast
Ep 83 Nexvax2 - What's Next?
On Episode 76 of the podcast, I spoke with Kristen Kneff from ImmunsanT about the presentation she gave at The State of Celiac event held in May by the Canadian Celiac Association. Kristen's presentation, and our subsequent interview looked at the Phase 2 trial for Nexvax2, a vaccine to minimize the effects of gluten on those with celiac disease. Recently, the trial was halted, as the vaccine was not performing as expected.
Ellen Bayens of theceliacscene.com brought this to my attention in an article looking at both the press release from ImmunsanT and a position piece from Dr. Peter Green…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.